Hereditary Angioedema Market Report

Hereditary Angioedema Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Feb 18, 2020
  • PAGES：170
  • REPORT CODE：GMM476349
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Hereditary Angioedema market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period.

    This report presents the market size and development trends by detailing the Hereditary Angioedema market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Hereditary Angioedema market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Hereditary Angioedema industry and will help you to build a panoramic view of the industrial development.

    Hereditary Angioedema Market, By Type:

    • C1 Esterase Inhibitor

    • Kallikrein Inhibitor

    • Selective Bradykinin B2 Receptor Antagonist

    Hereditary Angioedema Market, By Application:

    • Retail Pharmacies

    • Hospital Pharmacies

    • Online Pharmacies

    Some of the leading players are as follows:

    • Shire plc

    • iBio Inc

    • Pharming Group NV.

    • Ionis Pharmaceuticals, Inc.

    • CSL Limited.

    • BioCryst Pharmaceuticals, Inc

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Hereditary Angioedema Market: Technology Type Analysis

    • 4.1 Hereditary Angioedema Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Hereditary Angioedema Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 C1 Esterase Inhibitor

      • 4.3.2 Kallikrein Inhibitor

      • 4.3.3 Selective Bradykinin B2 Receptor Antagonist

    5 Hereditary Angioedema Market: Product Analysis

    • 5.1 Hereditary Angioedema Product Market Share Analysis, 2018 & 2026

    • 5.2 Hereditary Angioedema Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Hereditary Angioedema Market: Application Analysis

    • 6.1 Hereditary Angioedema Application Market Share Analysis, 2018 & 2026

    • 6.2 Hereditary Angioedema Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Retail Pharmacies

      • 6.3.2 Hospital Pharmacies

      • 6.3.3 Online Pharmacies

    7 Hereditary Angioedema Market: Regional Analysis

    • 7.1 Hereditary Angioedema Regional Market Share Analysis, 2018 & 2026

    • 7.2 Hereditary Angioedema Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Shire plc

      • 9.1.1 Shire plc Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 iBio Inc

      • 9.2.1 iBio Inc Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Pharming Group NV.

      • 9.3.1 Pharming Group NV. Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Ionis Pharmaceuticals, Inc.

      • 9.4.1 Ionis Pharmaceuticals, Inc. Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 CSL Limited.

      • 9.5.1 CSL Limited. Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 BioCryst Pharmaceuticals, Inc

      • 9.6.1 BioCryst Pharmaceuticals, Inc Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

     

    The List of Tables and Figures (Totals 89 Figures and 146 Tables)

    • Figure C1 Esterase Inhibitor Hereditary Angioedema market, 2015 - 2026 (USD Million)

    • Figure Kallikrein Inhibitor Hereditary Angioedema market, 2015 - 2026 (USD Million)

    • Figure Selective Bradykinin B2 Receptor Antagonist Hereditary Angioedema market, 2015 - 2026 (USD Million)

    • Figure Retail Pharmacies market, 2015 - 2026 (USD Million)

    • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

    • Figure Online Pharmacies market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Hereditary Angioedema market, by country, 2015 - 2026 (USD Million)

    • Table North America Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table North America Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table North America Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Canada Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Canada Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Europe Hereditary Angioedema market, by country, 2015 - 2026 (USD Million)

    • Table Europe Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Europe Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Europe Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Germany Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Germany Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table France Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table France Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Italy Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Italy Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Spain Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Spain Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Hereditary Angioedema market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table China Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table China Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Japan Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Japan Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table India Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table India Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Hereditary Angioedema market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table MEA Hereditary Angioedema market, by country, 2015 - 2026 (USD Million)

    • Table MEA Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table MEA Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table MEA Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Hereditary Angioedema market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Hereditary Angioedema market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Hereditary Angioedema market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Shire plc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table iBio Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pharming Group NV. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ionis Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CSL Limited. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BioCryst Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US